DK172013B1 - DNA, vektor indeholdende dette DNA, vært transformeret med vektoren,polypeptid indeholdt i DNA'et og salt deraf, aggregat indeholdende polypeptidet samt pharmaceutisk sammensætning indeholdende polypeptidet eller aggregatet. - Google Patents

DNA, vektor indeholdende dette DNA, vært transformeret med vektoren,polypeptid indeholdt i DNA'et og salt deraf, aggregat indeholdende polypeptidet samt pharmaceutisk sammensætning indeholdende polypeptidet eller aggregatet. Download PDF

Info

Publication number
DK172013B1
DK172013B1 DK100985A DK100985A DK172013B1 DK 172013 B1 DK172013 B1 DK 172013B1 DK 100985 A DK100985 A DK 100985A DK 100985 A DK100985 A DK 100985A DK 172013 B1 DK172013 B1 DK 172013B1
Authority
DK
Denmark
Prior art keywords
polypeptide
leu
formula
ser
ala
Prior art date
Application number
DK100985A
Other languages
Danish (da)
English (en)
Other versions
DK100985D0 (da
DK100985A (da
Inventor
Masaaki Yamada
Yasuji Furutani
Mitsue Notake
Juniti Yamagishi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59043617A external-priority patent/JPS60185799A/ja
Priority claimed from JP59082653A external-priority patent/JPS60232097A/ja
Priority claimed from JP59172307A external-priority patent/JP2584206B2/ja
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of DK100985D0 publication Critical patent/DK100985D0/da
Publication of DK100985A publication Critical patent/DK100985A/da
Application granted granted Critical
Publication of DK172013B1 publication Critical patent/DK172013B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK100985A 1984-03-06 1985-03-05 DNA, vektor indeholdende dette DNA, vært transformeret med vektoren,polypeptid indeholdt i DNA'et og salt deraf, aggregat indeholdende polypeptidet samt pharmaceutisk sammensætning indeholdende polypeptidet eller aggregatet. DK172013B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP4361784 1984-03-06
JP59043617A JPS60185799A (ja) 1984-03-06 1984-03-06 ヒト癌壊死因子
JP8265384 1984-04-23
JP59082653A JPS60232097A (ja) 1984-04-23 1984-04-23 ヒト癌壊死因子ポリペプチドの製造法
JP59172307A JP2584206B2 (ja) 1984-08-17 1984-08-17 ヒト癌壊死因子
JP17230784 1984-08-17

Publications (3)

Publication Number Publication Date
DK100985D0 DK100985D0 (da) 1985-03-05
DK100985A DK100985A (da) 1985-09-07
DK172013B1 true DK172013B1 (da) 1997-09-15

Family

ID=27291610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100985A DK172013B1 (da) 1984-03-06 1985-03-05 DNA, vektor indeholdende dette DNA, vært transformeret med vektoren,polypeptid indeholdt i DNA'et og salt deraf, aggregat indeholdende polypeptidet samt pharmaceutisk sammensætning indeholdende polypeptidet eller aggregatet.

Country Status (11)

Country Link
EP (1) EP0155549B1 (de)
KR (1) KR920010225B1 (de)
AU (1) AU584608B2 (de)
CA (1) CA1341240C (de)
DE (2) DE3582183D1 (de)
DK (1) DK172013B1 (de)
ES (2) ES8802159A1 (de)
FR (1) FR99C0037I2 (de)
HU (1) HU202921B (de)
NL (1) NL990034I2 (de)
PH (1) PH22108A (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
JPH0695939B2 (ja) * 1983-12-02 1994-11-30 大日本製薬株式会社 ウサギ癌壊死因子をコ−ドするクロ−ン化ｄνａ
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
GR851626B (de) * 1984-07-05 1985-11-26 Genentech Inc
EP0200748B1 (de) * 1984-10-15 1991-02-06 Cetus Corporation Menschlicher tumornekrosisfaktor
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
EP0368367A1 (de) * 1984-12-21 1990-05-16 Biogen, Inc. Reinigung, Herstellung und Verwendung von Tumornekrosefaktoren
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド
US5059530A (en) * 1985-09-30 1991-10-22 Suntory Ltd. Expression vector for human TNF
JPH0698004B2 (ja) * 1985-09-30 1994-12-07 サントリー株式会社 Ｔｎｆ発現用新規プラスミド
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US4677197A (en) * 1985-10-30 1987-06-30 Cetus Corporation Purification method for tumor necrosis factor
CA1286843C (en) * 1985-10-30 1991-07-23 Leo S. Lin Purification method for proteins
ATE116367T1 (de) * 1986-02-04 1995-01-15 Den Ichi Mizuno Für antitumor-polypeptide kodierende dns, die polypeptide und diese polypeptide enthaltenden antitumor-wirkstoffe.
KR940005589B1 (ko) * 1986-04-02 1994-06-21 다이닛뽄세이야꾸 가부시끼가이샤 핵산 또는 엔도톡신의 제거제 및 제거방법
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3750056T2 (de) * 1986-06-20 1995-04-06 Dainippon Pharmaceutical Co Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
WO1988006625A2 (en) * 1987-02-26 1988-09-07 Cetus Corporation Arginine-depleted human tumor necrosis factor
DE3716513A1 (de) * 1987-05-16 1988-11-24 Basf Ag Proteine mit tnf-wirkung
JP2828988B2 (ja) * 1988-04-03 1998-11-25 源一郎 杣 新規ｄｎａとその生産方法、それを有する新規プラスミド、新規ポリペプチドとその生産方法、及び該ポリペプチドからなる新規抗腫瘍剤
GB2217325B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene for tumour necrosis factor alpha.
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
EP0491878B1 (de) 1989-08-16 1997-02-19 Chiron Corporation Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
WO1991017180A1 (en) * 1990-04-27 1991-11-14 Peptide Technology Ltd Peptides derived from human tumour necrosis factor alpha and useful against intracellular malarial parasites
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
EP0749494A1 (de) 1994-03-07 1996-12-27 Chiron Corporation Zusammensetzungen zur hemmung der bildung von tnf und deren verwendungen
US6395273B1 (en) 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
ES2151403B1 (es) * 1998-07-13 2001-07-01 Hernandez Bronchud Miguel Linea celular transformada de rata productora de tnf-alfa humano recombinante.
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
EP3936137A1 (de) 2013-02-07 2022-01-12 The General Hospital Corporation Verfahren zur expansion oder abreicherung von t-regulatorischen zellen
CN113748192B (zh) 2019-04-12 2023-08-29 埃科莱布美国股份有限公司 抗微生物多用途清洁剂及其制备和使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
JPS60260522A (ja) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd 遺伝子組換体が生産する生理活性物質の安定化法
GR851626B (de) * 1984-07-05 1985-11-26 Genentech Inc
EP0200748B1 (de) * 1984-10-15 1991-02-06 Cetus Corporation Menschlicher tumornekrosisfaktor
JPS61124392A (ja) * 1984-11-22 1986-06-12 Asahi Chem Ind Co Ltd 遺伝子組換体の産生する生理活性物質の精製法

Also Published As

Publication number Publication date
ES8703490A1 (es) 1987-02-16
FR99C0037I2 (de) 2000-10-27
HU202921B (en) 1991-04-29
NL990034I1 (nl) 1999-12-01
ES550939A0 (es) 1987-02-16
FR99C0037I1 (de) 1999-12-10
KR850006874A (ko) 1985-10-21
PH22108A (en) 1988-06-01
ES8802159A1 (es) 1988-04-01
EP0155549B1 (de) 1991-03-20
EP0155549A2 (de) 1985-09-25
CA1341240C (en) 2001-06-05
HUT37957A (en) 1986-03-28
AU584608B2 (en) 1989-06-01
DE19975063I2 (de) 2005-08-18
DK100985D0 (da) 1985-03-05
KR920010225B1 (ko) 1992-11-21
DE19975063I1 (de) 2005-07-14
DE3582183D1 (de) 1991-04-25
AU3944885A (en) 1985-09-12
DK100985A (da) 1985-09-07
EP0155549A3 (en) 1986-12-30
NL990034I2 (nl) 2000-11-01
ES540939A0 (es) 1988-04-01

Similar Documents

Publication Publication Date Title
DK172013B1 (da) DNA, vektor indeholdende dette DNA, vært transformeret med vektoren,polypeptid indeholdt i DNA'et og salt deraf, aggregat indeholdende polypeptidet samt pharmaceutisk sammensætning indeholdende polypeptidet eller aggregatet.
US5288852A (en) Human tumor necrosis factor polypeptides
DK166832B1 (da) Rekombinante gamma-interferon-polypeptider, dna, som koder for dem, replicerbare udtrykkelsesvektorer, som kan udtrykke dem, transformante celler, som er transformeret med udtrykkelsesvektorerne, og farmaceutiske praeparater indeholdende polypeptider
JP2740417B2 (ja) ヒト神経成長因子の遺伝子組換えによる調製法
EP0188920B1 (de) Interleukin-1 und dessen Derivat
EP0251037B1 (de) Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS
JPH07308191A (ja) ハイブリド型ヒト白血球インタフェロンをコードするｄｎａ
IE913268A1 (en) Interleukin-1 beta protease and interleukin-1 beta protease¹inhibitors
NO169725B (no) Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein
US5043271A (en) DNA encoding rabbit TNE, vector having said DNA inserted thereinto, host transformed with said vector, rabbit TNF polypeptide, and process for production thereof
IL76699A (en) Recombinant human tumor necrosis factor, its production and pharmaceutical compositions containing it
CA2111327A1 (en) Cysteine depleted il-6 muteins
SU1614765A3 (ru) Способ получени рекомбинантной плазмидной ДНК pHTN 713, кодирующей фактор некроза опухоли человека
AU643194B2 (en) Recombinant fish hormone proteins
CN1032019C (zh) 生物合成灭活素的方法
EP0230781A2 (de) Lymphotoxin-Gen, Verfahren zu dessen Herstellung und Lymphotoxin
JP2675294B2 (ja) ヒト腫瘍壊死因子
CN1300170C (zh) 新型DnaJ/Hsp40分子DC－DJIII，其编码序列及用途
CA2174089A1 (en) Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors
JP2584206B2 (ja) ヒト癌壊死因子
JP2721854B2 (ja) 抗腫瘍活性物質
CS273182B2 (en) Method of expressive vector production capable to give mature human leucocytic interferon in transformed strain of escherichia coli by means of expression
CN1440981A (zh) 新型重组组织因子抑制肽及其制备方法和应用
JPS61257999A (ja) 魚類のプロラクチンポリペプチド

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1999 00025, 19991011, EXPIRES: 20100305

PUP Patent expired